Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A4250 in Children with Cholestatic Pruritus
2015-001157-32Phase 2Completed
- Sponsor
- Albireo Pharma
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of odevixibat in cholestatic pruritus and cholestatic disease, sponsored by Albireo Pharma. Primary endpoint: Change in total serum bile acids. Started Mar 2015; status: completed.
02
Drugs
odevixibat
03
Conditions
cholestatic prurituscholestatic disease
Beyond the preview
Go deeper on 2015-001157-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001157-32.